- Home
- MLAB vs GGN Comparison
MLAB vs GGN Comparison
Compare MLAB & GGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLAB
- GGN
- Stock Information
- Founded
- MLAB 1982
- GGN 2005
- Country
- MLAB United States
- GGN United States
- Employees
- MLAB N/A
- GGN N/A
- Industry
- MLAB Industrial Machinery/Components
- GGN Finance/Investors Services
- Sector
- MLAB Industrials
- GGN Finance
- Exchange
- MLAB Nasdaq
- GGN Nasdaq
- Market Cap
- MLAB 680.0M
- GGN 648.9M
- IPO Year
- MLAB N/A
- GGN N/A
- Fundamental
- Price
- MLAB $123.84
- GGN $4.31
- Analyst Decision
- MLAB Hold
- GGN
- Analyst Count
- MLAB 2
- GGN 0
- Target Price
- MLAB $140.00
- GGN N/A
- AVG Volume (30 Days)
- MLAB 38.2K
- GGN 397.4K
- Earning Date
- MLAB 05-30-2025
- GGN 01-01-0001
- Dividend Yield
- MLAB 0.52%
- GGN 10.26%
- EPS Growth
- MLAB N/A
- GGN N/A
- EPS
- MLAB N/A
- GGN N/A
- Revenue
- MLAB $237,747,000.00
- GGN N/A
- Revenue This Year
- MLAB $13.48
- GGN N/A
- Revenue Next Year
- MLAB $4.74
- GGN N/A
- P/E Ratio
- MLAB N/A
- GGN N/A
- Revenue Growth
- MLAB 11.68
- GGN N/A
- 52 Week Low
- MLAB $83.68
- GGN $3.51
- 52 Week High
- MLAB $155.12
- GGN $3.91
- Technical
- Relative Strength Index (RSI)
- MLAB 58.56
- GGN 58.06
- Support Level
- MLAB $116.81
- GGN $4.17
- Resistance Level
- MLAB $128.55
- GGN $4.27
- Average True Range (ATR)
- MLAB 4.62
- GGN 0.06
- MACD
- MLAB 1.56
- GGN 0.01
- Stochastic Oscillator
- MLAB 76.09
- GGN 94.12
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
About GGN GAMCO Global Gold Natural Resources & Income Trust
GAMCO Global Gold Natural Resources & Income Trust is a non-diversified closed-end management investment company. Its primary investment objective is to provide a high current income and capital appreciation as its secondary objective. To achieve its objective, the fund may invest majority of its assets in equity securities of companies principally engaged in the gold and natural resources industries. It also intends to earn income through an option planning of writing (selling) covered call options on equity securities in its portfolio.